DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Online

Drug Development Phase 1

Examine the activities associated with phase 1 development, with a focus on the drivers that impact the design of the first-in-human study.

概要

The Drug Development Phase 1 module is part of the DIA Drug Development and Lifecycle Management eLearning Program. In this module, learners will be taken through the activities associated with phase 1 development, with a focus on the drivers that impact the design of the first-in-human study. 

Estimated time to complete module: 1 hour

This eLearning module can be purchased individually or as part of the Drug Development and Lifecycle Management eLearning Program.

 

特集トピック

  • Objectives and key players
  • The IND and CTA
  • Phase 1 studies
  • Phase 1 decisions
  • Review

参加対象

This module is designed for individuals who are new to, or changing roles in, the pharmaceutical and biotechnology industries. The module will also benefit professionals who work in the areas of:

  • Clinical Research
  • Project Management
  • Administrative Support
  • Quality Assurance
  • Regulatory Affairs
  • Manufacturing
  • Medical writing
  • Business Support

学習目的

  • At the conclusion of this course, participants should be able to:

    • Identify the key objectives of phase 1 studies
    • Determine the regulatory submissions required for phase 1 studies
    • List key activities that need to be completed before first-in-human clinical trials can begin
    • Recognize risk-return decisions involved in phase 1 studies

    最新情報や機会を逃さないで

    DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。